<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04377958</url>
  </required_header>
  <id_info>
    <org_study_id>s52549</org_study_id>
    <nct_id>NCT04377958</nct_id>
  </id_info>
  <brief_title>Development and Validation of a Serum Biomarker for the Diagnostic Work-up of Asthma</brief_title>
  <official_title>Development and Validation of a Serum Biomarker for the Diagnostic Work-up of Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KU Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>KU Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Serum samples of asthmatic patients will be screened for serum biomarkers
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2016</start_date>
  <completion_date type="Actual">May 2020</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum calprotectin</measure>
    <time_frame>Day 1</time_frame>
    <description>Serum Calprotectin (pg/ml) will be measured in serum samples using a U-plex assay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sputum calprotectin</measure>
    <time_frame>Day 1</time_frame>
    <description>Sputum Calprotectin (pg/ml) will be measured in sputum samples using a U-plex assay</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">117</enrollment>
  <condition>Asthma</condition>
  <condition>Biomarkers</condition>
  <arm_group>
    <arm_group_label>Asthmatics</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Asthmatic group from which serum samples will be collected for analysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Serum biomarker testing</intervention_name>
    <description>Serum and sputum samples will be collected and biomarkers will be evaluated using ELISA</description>
    <arm_group_label>Asthmatics</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 - 65 years

          -  physician-diagnosed asthma

        Exclusion Criteria:

          -  No clear asthma phenotype

          -  Presence of other pulmonary diseases (Chronic obstructive pulmonary disease,
             alfa-1-antitrypsine deficiency emphysema, Immunoglobulin E deficiency, allergic
             bronchopulmonary aspergillosis)

          -  &gt; 15 pack years

          -  No sputum available

          -  Respiratory infection

          -  Other inflammatory diseases (Rheumatoid Arthritis, Colitis Ulcerosa)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lieven Dupont</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2020</study_first_posted>
  <last_update_submitted>May 6, 2020</last_update_submitted>
  <last_update_submitted_qc>May 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>KU Leuven</investigator_affiliation>
    <investigator_full_name>Tatjana Decaesteker</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

